Transcript for Diffuse parenchymal lung disease
Diffuse parenchymal lung disease
Diffuse parenchymal lung diseases, or DPLDs are a group of rare lung disorders that affect the interstitium of the alveolar wall, the alveoli, as well as the blood vessels and pleura of the lungs.
Previously, they were called interstitial lung diseases because we thought that they only affected the interstitium.
Now, there are literally hundreds of DPLDs out there, so it’s more important to know how to classify them based on their key features than to memorize the names of an ever-growing list of diseases.
DPLDs can be broadly classified into those with a known cause, and those with an unknown cause which are also called idiopathic.
DPLDs that have a known cause can be subclassified into connective tissue diseases, like systemic lupus erythematosus, rheumatoid arthritis, or systemic sclerosis; occupational exposures, like asbestosis, silicosis and berylliosis; granulomatous diseases, like sarcoidosis and hypersensitivity pneumonitis; and treatment-induced causes, like the antiarrhythmic amiodarone, the antibiotic nitrafurantoin, the chemotherapeutic agents methotrexate, bleomycin and busulfan, as well as exposure to radiation.
Now, idiopathic DPLDs include many subtypes, but the most important one is idiopathic pulmonary fibrosis.
In all scenarios, tobacco smoking can potentially worsen an existing DPLD.
Now, DPLDs are classified this way because the known causes are often more treatable and relatively reversible compared to the idiopathic causes.
Consequently, when approaching a individual, it’s crucial to first think through the known causes.
Alright, now regardless of the cause, DPLDs share similar clinical, radiographic and pathological manifestations, which is why all these diseases are clumped under the DPLD umbrella.
Individuals with DPLD commonly present with shortness of breath that worsens with exertion and a dry cough over the course of months to years. But these are still broad symptom categories - so thinking through other clues can help.
Think of connective tissue diseases if there’s a woman in her 30s.
A history of occupational exposure may also clue to an occupational lung disease, such as asbestosis in a shipbuilder, berylliosis in an aerospace engineer, silicosis in a sandblaster, or hypersensitivity pneumonitis in a farmer exposed to bird droppings.
If a individual also has joint pain, think of rheumatoid arthritis, or go a step further, and think of the methotrexate that’s being used to treat their rheumatoid arthritis!
On examination, crackles may be heard on auscultation, and clubbing of the fingers may occur due to chronic hypoxia.
Blue discoloration of the skin and enlargement of the thyroid gland may indicate long-standing amiodarone use.
Violaceous discoloration around the eyelids called a heliotrope rash and purplish papules on the knuckles called Gottron’s papules indicate dermatomyositis, while a red malar rash across the nasal bridge suggests lupus.
When a DPLD is suspected, the best initial test is a chest x-ray, which usually shows non-specific interlacing web-like reticular infiltrates, or spherical nodular infiltrates, or a combination of both, called a reticulonodular pattern.
Alright, after a chest x-ray, the next step is a high resolution computed tomography or HRCT scan.
The HRCT gives more anatomical detail than the plain x-ray, and may show specific manifestations. For example, bilateral hilar adenopathy may indicate sarcoidosis.
Upper lobe calcified nodules called eggshell calcifications are characteristic of silicosis.
In idiopathic pulmonary fibrosis, the alveolar walls become so thick that the lung parenchyma gives the appearance of a honeycomb.
Pleural effusions may be seen in connective tissue diseases.
Also, a linear pleural plaque, which is a thick, white elevation of the pleura that may be calcified, points towards asbestosis.
Alright, now pulmonary function tests always show a restrictive pattern in DPLDs and this helps distinguish the disease from an obstructive disease like COPD or asthma.
The most important PFTs are the forced vital capacity, or FVC; which is the maximum amount of air the person can breathe out after a maximum inspiration - and the forced expiratory volume in the first second, or the FEV1; which is the maximum amount of the air the person breathes out in the first second.
In DPLDs, the FVC decreases, however, because there’s no airway obstruction, the FEV1 doesn’t decrease as much. So, the ratio of FEV1 to FVC will be normal or even high.
Also, because the lung is stiff, the lungs don’t expand properly, so the total lung capacity, or TLC and the residual volume, or RV are decreased.
Finally, because the alveoli are affected, gas exchange is impaired. Gas exchange can be tested by measuring the DLCO which involves allowing the individual to inhale a small amount of carbon monoxide and seeing how well it diffuses.
In DPLDs, the DLCO is decreased.
Now some additional labs may be obtained when suspecting a specific DPLD. For example, antinuclear antibodies, or ANA and rheumatoid factor can be obtained when suspecting a connective tissue disease.
In cases of sarcoidosis, granulomas secrete angiotensin converting enzyme, or ACE causing elevated ACE levels.